Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Improved Dual-Task Performance During Turning After a Single Session of Action Observation Training in Parkinson's Disease Patients
Movement Disorders
P2 - Poster Session 2 (8:00 AM-9:00 PM)
3-008
To assess the effect of a single session of action observation (AO) on spatio-temporal dual-task gait parameters, particularly during the turning phase, in Parkinson’s disease (PD) patients with postural instability and gait disorders (PIGD). 

PD-PIGD patients usually show reduced gait speed and postural stability performing attention-demanding tasks such as turning and dual-task. Difficulty performing dual-task is probably due to the automaticity loss and the consequent cognitive overload. Turning represents a challenge as it requests an increased cognitive load in order to modify the locomotor pattern and to increase interlimb coordination.

Fourteen PD-PIGD patients were included and randomized into two groups: “AO group” and “Control group”. Both groups performed a baseline evaluation including Timed Up and Go (TUG) test and TUG with cognitive dual-task (TUG-COG), which consisted in TUG while counting backwards by threes starting from 100 or 82. After the baseline acquisition, the AO group was asked to watch a video representing a high-quality TUG performance while the Control group observed images of static landscapes. After the video observation, both groups performed again TUG and TUG-COG. Spatio-temporal gait parameters were acquired using a six cameras SMART-DX7000 optoelectronic system.

After video observation, the AO group showed a significant improvement in execution time both in TUG and TUG-COG and in turning stride length during TUG, while Control group did not show significant changes. AO group also showed a trend toward an increased mean turning velocity during TUG-COG.

A single session of AO showed the possibility to improve mobility during TUG both with and without dual-task, particularly during turning. We hypothesized that AO might facilitate mobility by reducing the necessity to control movement also during dual-task. A randomized controlled trial investigating the effect of a longer AO training on dual-task gait abilities is needed to validate our hypothesis.
Authors/Disclosures
Elisabetta Sarasso
PRESENTER
Elisabetta Sarasso has nothing to disclose.
Federica Agosta (San Raffaele Scientific Institute) Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
No disclosure on file
Andrea Gardoni No disclosure on file
No disclosure on file
Andrea Tettamanti No disclosure on file
No disclosure on file
No disclosure on file
Massimo Filippi, MD, FÂé¶¹´«Ã½Ó³»­ (Ospedale San Raffaele, Neuroimaging Research Unit) Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.